Drugs / HPDSC
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02434965 | Dec 2019 → Jan 2021 | brain hypoxia - ischemia | New York Medical College | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HPDSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02434965 ↗ |
| Modality | Cell therapy | “human placental-derived stem cells (HPDSC)” NCT02434965 ↗ |
| Route | Intravenous | “intravenous administration of autologous cord blood (CB) and autologous human placental derived stem cells (HPDSC)” NCT02434965 ↗ |